Cargando…
Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study
BACKGROUND: Wearable device-based parameters (DBP) objectively describe gait and balance impairment in Parkinson’s disease (PD). We sought to investigate correlations between DBP of gait and balance and clinical scores, their respective changes throughout the inpatient multidisciplinary Parkinson’s...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553759/ https://www.ncbi.nlm.nih.gov/pubmed/35864214 http://dx.doi.org/10.1007/s00415-022-11257-x |
_version_ | 1784806550447063040 |
---|---|
author | Scherbaum, Raphael Moewius, Andreas Oppermann, Judith Geritz, Johanna Hansen, Clint Gold, Ralf Maetzler, Walter Tönges, Lars |
author_facet | Scherbaum, Raphael Moewius, Andreas Oppermann, Judith Geritz, Johanna Hansen, Clint Gold, Ralf Maetzler, Walter Tönges, Lars |
author_sort | Scherbaum, Raphael |
collection | PubMed |
description | BACKGROUND: Wearable device-based parameters (DBP) objectively describe gait and balance impairment in Parkinson’s disease (PD). We sought to investigate correlations between DBP of gait and balance and clinical scores, their respective changes throughout the inpatient multidisciplinary Parkinson’s Disease Multimodal Complex Treatment (PD-MCT), and correlations between their changes. METHODS: This exploratory observational study assessed 10 DBP and clinical scores at the start (T1) and end (T2) of a two-week PD-MCT of 25 PD in patients (mean age: 66.9 years, median HY stage: 2.5). Subjects performed four straight walking tasks under single- and dual-task conditions, and four balance tasks. RESULTS: At T1, reduced gait velocity and larger sway area correlated with motor severity. Shorter strides during motor-motor dual-tasking correlated with motor complications. From T1 to T2, gait velocity improved, especially under dual-task conditions, stride length increased for motor-motor dual-tasking, and clinical scores measuring motor severity, balance, dexterity, executive functions, and motor complications changed favorably. Other gait parameters did not change significantly. Changes in motor complications, motor severity, and fear of falling correlated with changes in stride length, sway area, and measures of gait stability, respectively. CONCLUSION: DBP of gait and balance reflect clinical scores, e.g., those of motor severity. PD-MCT significantly improves gait velocity and stride length and favorably affects additional DBP. Motor complications and fear of falling are factors that may influence the response to PD-MCT. A DBP-based assessment on admission to PD inpatient treatment could allow for more individualized therapy that can improve outcomes. TRIAL REGISTRATION NUMBER AND DATE: DRKS00020948 number, 30-Mar-2020, retrospectively registered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11257-x. |
format | Online Article Text |
id | pubmed-9553759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-95537592022-10-13 Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study Scherbaum, Raphael Moewius, Andreas Oppermann, Judith Geritz, Johanna Hansen, Clint Gold, Ralf Maetzler, Walter Tönges, Lars J Neurol Original Communication BACKGROUND: Wearable device-based parameters (DBP) objectively describe gait and balance impairment in Parkinson’s disease (PD). We sought to investigate correlations between DBP of gait and balance and clinical scores, their respective changes throughout the inpatient multidisciplinary Parkinson’s Disease Multimodal Complex Treatment (PD-MCT), and correlations between their changes. METHODS: This exploratory observational study assessed 10 DBP and clinical scores at the start (T1) and end (T2) of a two-week PD-MCT of 25 PD in patients (mean age: 66.9 years, median HY stage: 2.5). Subjects performed four straight walking tasks under single- and dual-task conditions, and four balance tasks. RESULTS: At T1, reduced gait velocity and larger sway area correlated with motor severity. Shorter strides during motor-motor dual-tasking correlated with motor complications. From T1 to T2, gait velocity improved, especially under dual-task conditions, stride length increased for motor-motor dual-tasking, and clinical scores measuring motor severity, balance, dexterity, executive functions, and motor complications changed favorably. Other gait parameters did not change significantly. Changes in motor complications, motor severity, and fear of falling correlated with changes in stride length, sway area, and measures of gait stability, respectively. CONCLUSION: DBP of gait and balance reflect clinical scores, e.g., those of motor severity. PD-MCT significantly improves gait velocity and stride length and favorably affects additional DBP. Motor complications and fear of falling are factors that may influence the response to PD-MCT. A DBP-based assessment on admission to PD inpatient treatment could allow for more individualized therapy that can improve outcomes. TRIAL REGISTRATION NUMBER AND DATE: DRKS00020948 number, 30-Mar-2020, retrospectively registered. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00415-022-11257-x. Springer Berlin Heidelberg 2022-07-21 2022 /pmc/articles/PMC9553759/ /pubmed/35864214 http://dx.doi.org/10.1007/s00415-022-11257-x Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Communication Scherbaum, Raphael Moewius, Andreas Oppermann, Judith Geritz, Johanna Hansen, Clint Gold, Ralf Maetzler, Walter Tönges, Lars Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study |
title | Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study |
title_full | Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study |
title_fullStr | Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study |
title_full_unstemmed | Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study |
title_short | Parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study |
title_sort | parkinson’s disease multimodal complex treatment improves gait performance: an exploratory wearable digital device-supported study |
topic | Original Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9553759/ https://www.ncbi.nlm.nih.gov/pubmed/35864214 http://dx.doi.org/10.1007/s00415-022-11257-x |
work_keys_str_mv | AT scherbaumraphael parkinsonsdiseasemultimodalcomplextreatmentimprovesgaitperformanceanexploratorywearabledigitaldevicesupportedstudy AT moewiusandreas parkinsonsdiseasemultimodalcomplextreatmentimprovesgaitperformanceanexploratorywearabledigitaldevicesupportedstudy AT oppermannjudith parkinsonsdiseasemultimodalcomplextreatmentimprovesgaitperformanceanexploratorywearabledigitaldevicesupportedstudy AT geritzjohanna parkinsonsdiseasemultimodalcomplextreatmentimprovesgaitperformanceanexploratorywearabledigitaldevicesupportedstudy AT hansenclint parkinsonsdiseasemultimodalcomplextreatmentimprovesgaitperformanceanexploratorywearabledigitaldevicesupportedstudy AT goldralf parkinsonsdiseasemultimodalcomplextreatmentimprovesgaitperformanceanexploratorywearabledigitaldevicesupportedstudy AT maetzlerwalter parkinsonsdiseasemultimodalcomplextreatmentimprovesgaitperformanceanexploratorywearabledigitaldevicesupportedstudy AT tongeslars parkinsonsdiseasemultimodalcomplextreatmentimprovesgaitperformanceanexploratorywearabledigitaldevicesupportedstudy |